Uric Acid
OtherWhat is Uric Acid?
Uric acid is the final breakdown product of purine metabolism in humans. Purines are nitrogen-containing compounds found in the DNA and RNA of all cells—they are both consumed in the diet (high in organ meats, red meat, shellfish, beer, and fructose-sweetened beverages) and produced endogenously through normal cell turnover. The enzyme xanthine oxidase converts hypoxanthine and xanthine into uric acid, which circulates in the blood, is filtered by the kidneys, and is primarily excreted in urine (about 70%) with the remainder eliminated through the gastrointestinal tract.
Humans have higher uric acid levels than most mammals because we lack the enzyme uricase, which breaks down uric acid to the more soluble allantoin. At concentrations above the saturation point (approximately 6.8 mg/dL at body temperature), uric acid can crystallize as monosodium urate, depositing in joints, soft tissues, and the kidneys. This crystallization is the fundamental mechanism of gout—one of the most common and painful forms of inflammatory arthritis. Beyond gout, elevated uric acid (hyperuricemia) has been increasingly recognized as an independent risk factor for cardiovascular disease, chronic kidney disease, hypertension, and metabolic syndrome.
Why It Matters
Uric acid is clinically important for multiple reasons. Hyperuricemia is the prerequisite for gout, which affects approximately 4% of American adults and causes excruciating joint inflammation. Uric acid kidney stones account for about 10% of all kidney stones. Emerging evidence links elevated uric acid to hypertension, cardiovascular disease, chronic kidney disease progression, and metabolic syndrome—though whether uric acid is a causal factor or merely a marker remains debated. Monitoring uric acid is essential for gout management, tumor lysis syndrome prevention, and kidney stone risk assessment.
Normal Reference Ranges
| Group | Range | Unit |
|---|---|---|
| Adult Men | 3.5–7.2 | mg/dL |
| Adult Women (premenopausal) | 2.5–6.0 | mg/dL |
| Adult Women (postmenopausal) | 3.5–7.0 | mg/dL |
| Gout Treatment Target | <6.0 | mg/dL |
| Children | 2.0–5.5 | mg/dL |
Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.
What High UA Levels Mean
Common Causes
- Gout
- High-purine diet (organ meats, red meat, shellfish)
- Excessive alcohol intake (especially beer)
- Fructose and sugar-sweetened beverage consumption
- Obesity and metabolic syndrome
- Chronic kidney disease (reduced excretion)
- Medications (thiazide diuretics, low-dose aspirin, cyclosporine)
- Tumor lysis syndrome (rapid cell destruction from chemotherapy)
- Myeloproliferative and lymphoproliferative disorders
- Psoriasis (increased cell turnover)
- Lead poisoning (saturnine gout)
Possible Symptoms
- Gout flare: sudden, severe joint pain (classically the big toe), redness, swelling, warmth
- Tophi: visible uric acid crystal deposits under skin (in chronic gout)
- Kidney stones: flank pain, blood in urine, nausea
- Asymptomatic hyperuricemia (elevated uric acid without symptoms—most common)
What to do: Acute gout flares are treated with NSAIDs, colchicine, or corticosteroids. Long-term urate-lowering therapy (ULT) is indicated for patients with ≥2 gout flares per year, tophi, uric acid kidney stones, or chronic kidney disease. Allopurinol (xanthine oxidase inhibitor) is first-line, typically started at 100 mg daily and titrated to achieve uric acid <6.0 mg/dL. Febuxostat is an alternative. Probenecid (uricosuric) promotes renal excretion. Lifestyle modifications: limit purine-rich foods, reduce alcohol (especially beer), limit fructose/sugar, maintain healthy weight, and stay well-hydrated. For tumor lysis syndrome, rasburicase (recombinant uricase) rapidly lowers uric acid.
What Low UA Levels Mean
Common Causes
- Low-purine diet
- Allopurinol or febuxostat therapy (therapeutic)
- Fanconi syndrome (renal tubular defect)
- Wilson's disease
- SIADH (syndrome of inappropriate antidiuretic hormone)
- Severe liver disease
- Xanthine oxidase deficiency (rare genetic condition)
- High-dose aspirin (uricosuric effect at >3 g/day)
Possible Symptoms
- Low uric acid is usually asymptomatic
- Very low levels (<2 mg/dL) may be associated with increased oxidative stress (uric acid has antioxidant properties)
- Some studies suggest association with multiple sclerosis, Parkinson's, and Alzheimer's at very low levels
What to do: Low uric acid (<2 mg/dL) that is unexplained warrants investigation for renal tubular disorders (check urine uric acid, phosphorus, glucose, amino acids for Fanconi syndrome), Wilson's disease (ceruloplasmin), or SIADH (sodium, osmolality). If due to urate-lowering therapy for gout, levels <3 mg/dL may prompt dose reduction. Mildly low levels in the absence of symptoms or underlying disease generally require no treatment.
When Is UA Testing Recommended?
- When gout is suspected (acute joint inflammation)
- To monitor urate-lowering therapy in gout patients
- Evaluation of recurrent kidney stones (uric acid stones)
- Before chemotherapy for cancers at risk of tumor lysis syndrome
- As part of metabolic and cardiovascular risk assessment
- When diuretic therapy is initiated (can raise uric acid)
- Unexplained joint pain or swelling
Frequently Asked Questions
Related Biomarkers
Want your UA levels analyzed?
Upload your lab results for an instant AI-powered breakdown of all your biomarkers.
Upload Lab Results →Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.